Loading...
Empagliflozin
India Pharmaceutical Trade Intelligence
Who Supplies Empagliflozin to India from GREECE
India's empagliflozin imports from GREECE total $37.7B across 70 shipments from 6 foreign suppliers. BOEHRINGER INGELHEIM INTERNATIONAL leads with $37.7B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for empagliflozin — a diversified sourcing base with multiple active suppliers from GREECE.
Top foreign suppliers (GREECE) — Ranked by import value
BOEHRINGER INGELHEIM INTERNATIONAL is the leading Empagliflozin supplier from GREECE to India, with import value of $37.7B across 50 shipments. The top 5 suppliers — BOEHRINGER INGELHEIM INTERNATIONAL, PRIVAPOSERVICES GMBH, XXSHEXXCLIXXCALXXERVXXES, PHARMA PATH SA, PHARMAPATH S.A — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (GREECE)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BOEHRINGER INGELHEIM INTERNATIONAL | $37.7B | 50 | 100.0% |
| 2 | PRIVAPOSERVICES GMBH | $2.8K | 10 | 0.0% |
| 3 | XXSHEXXCLIXXCALXXERVXXES | $122 | 1 | 0.0% |
| 4 | PHARMA PATH SA | $27 | 4 | 0.0% |
| 5 | PHARMAPATH S.A | $21 | 4 | 0.0% |
| 6 | PHARMA PATH A.B.E.E | $5 | 1 | 0.0% |
Showing top 6 of 6 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from GREECE)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED | $37.7B | 50 | 100.0% |
| 2 | CENTAUR PHARMACEUTICALS PRIVATE LIMITED | $1.9K | 8 | 0.0% |
| 3 | COPMED PHARMACEUTICALS PRIVATE LIMITED | $936 | 2 | 0.0% |
| 4 | FISHER BIOPHARMA SERVICES (INDIA) PRIVATE LIMITED | $122 | 1 | 0.0% |
| 5 | FINOSO PHARMA PRIVATE LIMITED | $32 | 5 | 0.0% |
| 6 | QPS BIOSERVE INDIA PRIVATE LIMITED | $21 | 4 | 0.0% |
Import Statistics
- Import Value
- $37.7B
- Shipments
- 70
- Foreign Suppliers
- 6
- Indian Buyers
- 6
- Avg. Shipment
- $538.2M
Other Empagliflozin Import Origins
Related Analysis
Frequently Asked Questions — Empagliflozin Imports from GREECE
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Empagliflozin suppliers from GREECE to India?
The top Empagliflozin suppliers from GREECE to India include BOEHRINGER INGELHEIM INTERNATIONAL, PRIVAPOSERVICES GMBH, XXSHEXXCLIXXCALXXERVXXES. The leading supplier is BOEHRINGER INGELHEIM INTERNATIONAL with import value of $37.7B USD across 50 shipments. India imported Empagliflozin worth $37.7B USD from GREECE in total across 70 shipments.
QHow much Empagliflozin does India import from GREECE?
India imported Empagliflozin worth $37.7B USD from GREECE across 70 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Empagliflozin from GREECE?
The main Indian buyers of Empagliflozin sourced from GREECE include BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED, CENTAUR PHARMACEUTICALS PRIVATE LIMITED, COPMED PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED with $37.7B in imports across 50 shipments.
QWhat is the total value of Empagliflozin imports from GREECE to India?
The total value of Empagliflozin imports from GREECE to India is $37.7B USD, across 70 shipments and 6 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: GREECE to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Empagliflozin.
- 2.Supplier/Buyer Matching: 6 foreign suppliers from GREECE and 6 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $37.7B aggregated from 70 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
70 Verified Shipments
6 suppliers, 6 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists